PL450520A1 - Nanokompozytowy materiał opatrunkowy na rany wzbogacony o nanocząstki srebra oraz sposób jego wytwarzania - Google Patents

Nanokompozytowy materiał opatrunkowy na rany wzbogacony o nanocząstki srebra oraz sposób jego wytwarzania

Info

Publication number
PL450520A1
PL450520A1 PL450520A PL45052024A PL450520A1 PL 450520 A1 PL450520 A1 PL 450520A1 PL 450520 A PL450520 A PL 450520A PL 45052024 A PL45052024 A PL 45052024A PL 450520 A1 PL450520 A1 PL 450520A1
Authority
PL
Poland
Prior art keywords
silver nanoparticles
nanocomposite
dressing material
curdlan
agarose
Prior art date
Application number
PL450520A
Other languages
English (en)
Inventor
Michał Wójcik
Agata Przekora-Kuśmierz
Original Assignee
Uniwersytet Medyczny W Lublinie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny W Lublinie filed Critical Uniwersytet Medyczny W Lublinie
Priority to PL450520A priority Critical patent/PL450520A1/pl
Publication of PL450520A1 publication Critical patent/PL450520A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/04—Coatings containing a composite material such as inorganic/organic, i.e. material comprising different phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest nanokompozytowy materiał opatrunkowy na rany na bazie kurdlanu wzbogacony o nanocząstki srebra, który charakteryzuje się tym, że tworzą go kurdlan (bakteryjny â-1,3-D-glukan), agaroza oraz nanocząstki srebra Ag(0) zawieszone w wodzie destylowanej lub dejonizowanej, gdzie proporcje wagowe składników stanowią 1% - 15% (w/v) kurdlanu, 1% - 5% (w/v) agarozy, 30% - 60% (w/v) nanocząstek srebra Ag(0) w odniesieniu do fazy wodnej. Zgłoszenie obejmuje także sposób wytwarzania nanokompozytowego materiału opatrunkowego, który polega na zmieszaniu polisacharydów w wodzie destylowanej lub dejonizowanej, gdzie proporcje wagowe składników wynoszą 1% - 15% (w/v) kurdlanu, 1% - 5% (w/v) agarozy, 30% - 60% (w/v) nanocząstek srebra Ag(0) w odniesieniu do fazy wodnej, po czym całość podgrzewa się do ich rozpuszczania, dodaje się nanocząstki srebra i dokładnie miesza z matrycą polimerową i poddaje termożelowaniu, mrożeniu i liofilizacji. Nanokompozytowy materiał opatrunkowy wytworzony według wynalazku może znaleźć zastosowanie w medycynie regeneracyjnej do zaopatrywania zakażonych ran wysiękowych lub jako opatrunek zapobiegający kontaminacji mikrobiologicznej rany.
PL450520A 2024-12-10 2024-12-10 Nanokompozytowy materiał opatrunkowy na rany wzbogacony o nanocząstki srebra oraz sposób jego wytwarzania PL450520A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL450520A PL450520A1 (pl) 2024-12-10 2024-12-10 Nanokompozytowy materiał opatrunkowy na rany wzbogacony o nanocząstki srebra oraz sposób jego wytwarzania

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL450520A PL450520A1 (pl) 2024-12-10 2024-12-10 Nanokompozytowy materiał opatrunkowy na rany wzbogacony o nanocząstki srebra oraz sposób jego wytwarzania

Publications (1)

Publication Number Publication Date
PL450520A1 true PL450520A1 (pl) 2026-06-15

Family

ID=100212529

Family Applications (1)

Application Number Title Priority Date Filing Date
PL450520A PL450520A1 (pl) 2024-12-10 2024-12-10 Nanokompozytowy materiał opatrunkowy na rany wzbogacony o nanocząstki srebra oraz sposób jego wytwarzania

Country Status (1)

Country Link
PL (1) PL450520A1 (pl)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL236367B1 (pl) * 2019-07-01 2021-01-11 Univ Medyczny W Lublinie Piankowy materiał opatrunkowy na rany na bazie agarozy oraz sposób jego wytwarzania

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL236367B1 (pl) * 2019-07-01 2021-01-11 Univ Medyczny W Lublinie Piankowy materiał opatrunkowy na rany na bazie agarozy oraz sposób jego wytwarzania

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MDPI; Elizaveta S. Permyakova "Ag-Contained Superabsorbent Curdlan–Chitosan Foams for Healing Wounds in a Type-2 Diabetic Mice Model", Pharmaceutics 2022, 14, 724. https://doi.org/10.3390/pharmaceutics14040724 *
ScienceDirect; M. Wojcik, P. Kazimierczak , A. Benko , K. Palka, V. Vivcharenko , A. Przekora "Superabsorbent curdlan-based foam dressings with typical hydrocolloids properties for highly exuding wound management", Materials Science & Engineering C 124 (2021) 112068, https://doi.org/10.1016/j.msec.2021.112068 *